Structure of Pycnonodysostosis disease related I249T mutant of human cathepsin K homo-2-mer 16-329
99.35 8×GOL; 16×EDO; 5×SO4; 7×PEG; 1×CL; 1×NA; 3×MPD; CRYSTAL STRUCTURE OF WILD TYPE HUMAN PROCATHEPSIN K homo-2-mer 16-329
100 Structure of the activation intermediate of cathepsin K in complex with the 3-cyano-3-aza-beta-amin… homo-2-mer 23-329
100 1×A0U; 1×ACT; 1×MG; Structure of the activation intermediate of cathepsin K in complex with the azadipeptide nitrile in… homo-2-mer 23-329
100 1×9ZG; 3×EDO; 1×CL; 1×MG; The Alkyne Moiety as a Latent Electrophile in Irreversible Covalent Small Molecule Inhibitors of Ca… homo-2-mer 115-329
100 2×HVW; 1×CA; 2×CL; Cathepsin K complexed with a ketoamide inhibitor homo-2-mer 115-329
100 3×SO4; 2×FSP; Crystal structure of the cathepsin K : chondroitin sulfate complex. homo-2-mer 115-329
100 2×BDP; 2×CA; 2×E64; THE CRYSTAL STRUCTURE OF HUMAN PROCATHEPSIN K monomer 20-329
100 Human cathepsin K mutant C25S in complex with the allosteric effector NSC13345 monomer 107-329
99.55 1×1XF; 1×SO4; Human cathepsin K mutant C25S in complex with the allosteric effector NSC94914 monomer 108-329
99.55 1×6HM; 1×SO4; Structure of cathepsin K in complex with the azadipeptide nitrile inhibitor Gu1303 monomer 113-329
100 1×9ZG; 1×CL; 1×ACT; Cathepsin-K in complex with MIV-711 monomer 113-329
100 1×J5N; 6×NO3; Cathepsin-K in complex with MIV-701 monomer 114-329
100 1×HFH; 1×GOL; 1×NA; Structure of human cathepsin K in complex with the selective activity-based probe Gu3416 monomer 114-329
100 1×SO4; 1×UUW; Structure of human cathepsin K in complex with the acrylamide inhibitor Gu3110 monomer 114-329
100 1×SO4; 1×UUK; Cathepsin-K in complex with amino-oxaazabicyclo[3.3.0]octanyl containing inhibitor monomer 114-329
100 1×MHA; 1×J6B; Crystal structure of a pyrrolopyrimidine inhibitor in complex with human Cathepsin K monomer 114-329
100 1×CKE; Cathepsin-K in complex with MIV-710 monomer 114-329
100 1×J5T; 3×CL; 1×NA; Crystal Structure of the Cysteine Protease Human Cathepsin K in Complex with the Covalent Inhibitor… monomer 114-329
100 1×IHJ; Cathepsin-K in complex with fluoro-oxa-azabicyclo[3.3.0]octanyl containing inhibitor monomer 114-329
100 1×HKH; Crystal Structure of the Cysteine Protease Human Cathepsin K in Complex with the Covalent Inhibitor… monomer 114-329
100 1×IHI; Development of N-(Functionalized benzoyl)-homocycloleucyl-glycinonitriles as Potent Cathepsin K Inh… monomer 115-329
100 1×3XT; 1×I37; 6×SO4; Crystal structure of Cathepsin K with a covalently-linked inhibitor at 1.4 Angstrom resolution. monomer 115-329
99.53 1×7AS; Crystal structure of human Cathepsin K with a non-active site inhibitor at 1.42 Angstrom resolution monomer 115-329
99.53 3×1XF; Cathepsin K in complex with a non-selective 2-cyano-pyrimidine inhibitor monomer 115-329
100 6×SO4; 1×KWZ; Development of N-(Functionalized benzoyl)-homocycloleucyl-glycinonitriles as Potent Cathepsin K Inh… monomer 115-329
100 1×GOL; 1×CL; 1×K; 3×PGO; 1×3Y2; Crystal structure of uninhibited human Cathepsin K at 1.62 Angstrom resolution monomer 115-329
100 Cathepsin K inhibitor monomer 115-329
100 1×0LC; 2×SO4; Cathepsin K covalently bound to a 2-cyano pyrimidine inhibitor with a benzyl P3 group. monomer 115-329
100 2×SO4; 1×O75; Cathepsin K inhibitor monomer 115-329
100 1×0LB; 1×GOL; Crystal structure of Cathepsin K complexed with a potent vinyl sulfone inhibitor monomer 115-329
100 1×0D6; Cathepsin K covalently bound to a cyano-pyrimidine inhibitor with improved selectivity over hERG monomer 115-329
100 1×O47; X-ray structure of Cathepsin K covalently bound to a triazine ligand monomer 115-329
100 1×ORG; 1×TFA; Structure of human Cathepsin K with an ectosteric inhibitor at 1.85 Angstrom resolution monomer 115-329
99.53 4×J0V; Development of N-(Functionalized benzoyl)-homocycloleucyl-glycinonitriles as Potent Cathepsin K Inh… monomer 115-329
100 1×3Y1; 5×SO4; Sulfonated Calpeptin is a promising drug candidate against SARS-CoV-2 infections monomer 115-329
100 1×CA; Cathepsin K complexed with a pyrrolidine ketoamide-based inhibitor monomer 115-329
100 1×4PR; Structure of cathepsin K in complex with the 3-cyano-3-aza-beta-amino acid inhibitor Gu2602 monomer 115-329
100 1×A0U; Crystal structure of a potent small molecule inhibitor bound to cathepsin K monomer 115-329
93.02 1×NFT; Crystal structure of Human Cathepsin K in complex with myocrisin monomer 115-329
100 1×SO4; 1×MYQ; Structure of CatK covalently bound to a dioxo-triazine inhibitor monomer 115-329
100 1×ORH; Cathepsin K complexed with t-butyl(1S)-1-cyclohexyl-2-oxoethylcarbamate monomer 115-329
100 1×SO4; 1×TCO; CRYSTAL STRUCTURE OF THE CYSTEINE PROTEASE HUMAN CATHEPSIN K IN COMPLEX WITH THE COVALENT INHIBITOR… monomer 115-329
100 1×E64; CRYSTAL STRUCTURE OF CYSTEINE PROTEASE HUMAN CATHEPSIN K IN COMPLEX WITH A COVALENT SYMMETRIC BISCA… monomer 115-329
100 1×INA; Crystal Structure of the Cysteine Protease Human Cathepsin K in Complex with the Covalent Inhibitor… monomer 115-329
100 1×IHE; CRYSTAL STRUCTURE OF CATHEPSIN K WITH N-DESMETHYL THALASSOSPIRAMIDE C monomer 115-329
100 1×G4B; The crystal structure of the cathepsin K Variant M5 in complex with chondroitin-4-sulfate monomer 115-329
97.21 1×BDP; 1×CA; 1×E64; CRYSTAL STRUCTURE OF CYSTEINE PROTEASE HUMAN CATHEPSIN K IN COMPLEX WITH A COVALENT PEPTIDOMIMETIC … monomer 115-329
100 1×I10; CRYSTAL STRUCTURE OF CYSTEINE PROTEASE HUMAN CATHEPSIN K IN COMPLEX WITH A COVALENT THIAZOLHYDRAZID… monomer 115-329
100 1×IN6; Cathepsin K complexed with a semicarbazone inhibitor monomer 115-329
100 3×SO4; 1×CT2; CRYSTAL STRUCTURE OF THE CYSTEINE PROTEASE HUMAN CATHEPSIN K IN COMPLEX WITH A COVALENT PYRROLIDINO… monomer 115-329
100 1×INP; CRYSTAL STRUCTURE OF THE CYSTEINE PROTEASE HUMAN CATHEPSIN K IN COMPLEX WITH A COVALENT AZEPANONE I… monomer 115-329
100 1×2CA; CRYSTAL STRUCTURE OF CYSTEINE PROTEASE HUMAN CATHEPSIN K IN COMPLEX WITH A COVALENT BENZYLOXYBENZOY… monomer 115-329
100 1×IN3; Cathepsin K complexed with a cyanopyrrolidine inhibitor monomer 115-329
100 1×NBL; CRYSTAL STRUCTURE OF THE CYSTEINE PROTEASE HUMAN CATHEPSIN K IN COMPLEX WITH A COVALENT PYRROLIDINO… monomer 115-329
100 1×PCM; CRYSTAL STRUCTURE OF THE CYSTEINE PROTEASE HUMAN CATHEPSIN K IN COMPLEX WITH A COVALENT SYMMETRIC D… monomer 115-329
100 1×SDK; CRYSTAL STRUCTURE OF THE CYSTEINE PROTEASE HUMAN CATHEPSIN K IN COMPLEX WITH A COVALENT PROPANONE I… monomer 115-329
100 1×POS; Structure of Cathepsin K-dermatan sulfate complex monomer 115-329
100 1×ASG; Crystal Structure Of The Cysteine Protease Human Cathepsin K In Complex With A Covalent Azepanone I… monomer 115-329
100 1×750; Human cathepsin K mutant C25S monomer 116-329
99.53 2×SO4; 1×ACT; 1×CL; Cathepsin K complexed with a constrained ketoamide inhibitor monomer 116-329
100 2×SO4; 1×3FC; Cathepsin K complexed with carbamate derivatized norleucine aldehyde monomer 116-329
100 3×SO4; 1×MYE; Cathepsin K in complex with a selective 2-cyano-pyrimidine inhibitor monomer 117-329
100 1×KX1; 2×SO4; Cathepsin K co-crystallized with actinomycetes extract monomer 117-329
100 1×SO4; Crystal structure of cathepsin K bound to the covalent inhibitor lichostatinal monomer 117-329
100 3×SO4; cathepsin K - chondroitin sulfate complex monomer 117-329
100 1×BDP; Cathepsin K complexed with a semicarbazone inhibitor monomer 117-329
100 1×CT1; Cathepsin K complexed with a cyanamide-based inhibitor monomer 117-329
100 1×T2M; Cathepsin K in complex with a covalent inhibitor with a ketoamide warhead monomer 121-329
100 1×O96; 2×SO4;